Alma John Carter, OD in Kennewick, WA - Medicare Optometrist Provider

Alma John Carter, OD is a medicare enrolled "Optometrist" provider in Kennewick, Washington. His current practice location is 8505 W Gage Blvd, Kennewick, Washington. You can reach out to his office (for appointments etc.) via phone at (509) 737-8868.

Alma John Carter is licensed to practice in Washington (license number 1153TX) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1003932856.

Contact Information

	Alma John Carter, OD
	8505 W Gage Blvd, Kennewick, WA 99336-8120
	(509) 737-8868
	Not Available

Healthcare Provider's Profile

Full Name	Alma John Carter
Gender	Male
Speciality	Optometrist
Location	8505 W Gage Blvd, Kennewick, Washington
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1003932856
Provider Enumeration Date: 03/22/2007
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 8729076252
Enrollment ID: I20040504000683

Medical Identifiers

Medical identifiers for Alma John Carter such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003932856	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	1153TX (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alma John Carter is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alma John Carter, OD 8505 W Gage Blvd, Kennewick, WA 99336-8120 Ph: (509) 737-8868	Alma John Carter, OD 8505 W Gage Blvd, Kennewick, WA 99336-8120 Ph: (509) 737-8868

News Archive

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women's Hospital, the H. Lee Moffitt Cancer Center, Dartmouth's Hitchcock Medical Center and the University of Sherbrooke to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies.

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.

Cultural frameworks and institutional practices for quality health care

As health care moves to the forefront of the national discourse, new research in the social sciences argues that the health of the population and the success or failure of many public health initiatives hinges as much on cultural and social factors as it does on doctors, facilities, or drugs.

ANAVEX 2-73 named 2010's 'most promising trial drug' by Alzheimer's Weekly

Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.

Immunity found 6 months after SARS-CoV-2 infection in children

A new study suggests that infection-induced antibodies persist, providing protection for at least six months.

Optometrist in Kennewick, WA

James E Kintner, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3700 W Clearwater Ave, Kennewick, WA 99336 Phone: 509-735-1312 Fax: 506-736-6403
Boyd Edward Robertson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7903 W Grandridge Blvd Ste A, Kennewick, WA 99336 Phone: 509-783-0667 Fax: 509-735-7981
Belinda Michelle Badorek, OD Optometrist Medicare: Medicare Enrolled Practice Location: 6515 W Clearwater Ave, Ste 340, Kennewick, WA 99336 Phone: 509-737-2020 Fax: 509-737-1036
Aric D Robertson Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1321 N Columbia Center Blvd, Kennewick, WA 99336 Phone: 509-735-3128 Fax: 509-736-2367
Canyonview Family Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 4309 W 27th Place, Suite 102, Kennewick, WA 99338 Phone: 509-737-2010 Fax: 509-737-2012
Dr. Virginia O Bice, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6695 W Rio Grande Ave, Kennewick, WA 99336 Phone: 509-736-0826 Fax: 509-735-6868

Alma John Carter, OD - Medicare Optometrist in Kennewick, WA